Status:
COMPLETED
Seasonal Factors and COVID 19
Lead Sponsor:
Izmir Katip Celebi University
Conditions:
COVID-19 Pandemic
Eligibility:
All Genders
18+ years
Brief Summary
Corona Virus - 19 Disease (COVID-19), caused by Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2), first appeared in Wuhan city of Hubei province of China and spread rapidly, causing a pan...
Detailed Description
From the first appearance of COVID-19 to the present, 336,790,193 people have been infected and 5,560,718 people have died (Web Page: https://covid19.who.int/ accessed on 21 January 2022). Considering...
Eligibility Criteria
Inclusion
- Patients with positive PCR test according to laboratory, imaging and PCR test results from adult patients who applied with Covid-19 symptoms or contact history, and patients diagnosed with COVID-19 as a result of imaging and clinical findings were included in the study.
Exclusion
- Patients under the age of 18 were excluded from these patients.
Key Trial Info
Start Date :
January 31 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 2 2022
Estimated Enrollment :
24225 Patients enrolled
Trial Details
Trial ID
NCT05264948
Start Date
January 31 2021
End Date
March 2 2022
Last Update
March 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IKCU, Atatürk Eğitim ve Araştırma Hastanesi, Acil Tıp
Izmir, Turkey (Türkiye), 35360